Ozelle launches artificial intelligence-based diagnostic device
Ozelle officially launched the EHBT-50 Mini Lab Multi-Functional Analyzer (EHBT-50 Mini Lab) in Indonesia, a comprehensive artificial intelligence (AI)-based diagnostic device intended for clinics and everyday medical practices.
"Together with local collaborators, we aim not only to bring innovation but also to improve diagnostic services in Indonesia," said spokesperson Ozelle Luke in a statement in Jakarta on Thursday.
This device relies on AI-powered Complete Blood Morphology (CBM), an automated integration of complete blood count and peripheral blood smear. This technology reduces reliance on manual testing and results in faster analysis with minimal human bias.
The EHBT-50 Mini Lab is designed to deliver intelligent diagnostics that accurately identify abnormal blood cells, while supporting earlier clinical decision-making.
Also read: BRIN reveals a number of challenges in implementing AI in the health sector
This device also enables all-in-one testing by integrating hematology, immunoassay, and biochemistry analysis into a single unit so that space, cost, and workflow can be optimized.
With a fully automated system, test results can be obtained in just six minutes from sample to report, without the need for manual handling.
Furthermore, this device uses disposable cartridges that can be stored at room temperature in a maintenance-free, dry system. This innovation is considered to prevent contamination, simplify logistics, and reduce operational costs.
With its simple design, the EHBT-50 Mini Lab is said to be easy to use, maintenance-free, and adaptable to the needs of primary healthcare facilities in various regions.
Ozelle plans to showcase the AI-powered product in Indonesia at the International Hospital Expo 2025 healthcare exhibition, which will take place from September 25–28 in Jakarta.
“The strong interest from doctors demonstrates the device’s potential to improve healthcare standards,” added Ozelle’s local partner representative.
